Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Yanish Purmah"'
Autor:
Winnie Chua, Victor R. Cardoso, Eduard Guasch, Moritz F. Sinner, Christoph Al-Taie, Paul Brady, Barbara Casadei, Harry J. G. M. Crijns, Elton A. M. P. Dudink, Stéphane N. Hatem, Stefan Kääb, Peter Kastner, Lluis Mont, Frantisek Nehaj, Yanish Purmah, Jasmeet S. Reyat, Ulrich Schotten, Laura C. Sommerfeld, Stef Zeemering, André Ziegler, Georgios V. Gkoutos, Paulus Kirchhof, Larissa Fabritz
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Early detection of atrial fibrillation (AF) enables initiation of anticoagulation and early rhythm control therapy to reduce stroke, cardiovascular death, and heart failure. In a cross-sectional, observational study, we aimed to identify a c
Externí odkaz:
https://doaj.org/article/d1c609a3c0d54b6f920d0755d796b56f
Autor:
Yanish Purmah, Aidan Cornhill, Lucy Y. Lei, Steven Dykstra, Yoko Mikami, Alessandro Satriano, Dina Labib, Jacqueline Flewitt, Sandra Rivest, Rosa Sandonato, Michelle Seib, Andrew G. Howarth, Carmen P. Lydell, Bobak Heydari, Naeem Merchant, Michael Bristow, Louis Kolman, Nowell M. Fine, James A. White
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Heart failure (HF) admission is a dominant contributor to morbidity and healthcare costs in dilated cardiomyopathy (DCM). Mid-wall striae (MWS) fibrosis by late gadolinium enhancement (LGE) imaging has been associated with elevated arrhythmi
Externí odkaz:
https://doaj.org/article/ca7fe4402c4d47189d50139c1f7c4ee0
Autor:
Winnie Chua, Jonathan P Law, Victor R Cardoso, Yanish Purmah, Georgiana Neculau, Muhammad Jawad-Ul-Qamar, Kalisha Russell, Ashley Turner, Samantha P Tull, Frantisek Nehaj, Paul Brady, Peter Kastner, André Ziegler, Georgios V Gkoutos, Davor Pavlovic, Charles J Ferro, Paulus Kirchhof, Larissa Fabritz
Publikováno v:
PLoS Medicine, Vol 18, Iss 2, p e1003405 (2021)
BackgroundLarge-scale screening for atrial fibrillation (AF) requires reliable methods to identify at-risk populations. Using an experimental semi-quantitative biomarker assay, B-type natriuretic peptide (BNP) and fibroblast growth factor 23 (FGF23)
Externí odkaz:
https://doaj.org/article/d0513127f00845409b6b8df1ebe0041f
Autor:
Paulus Kirchhof, Winnie Chua, Yanish Purmah, Russell Davis, Chetan Varma, Larissa Fabritz, Muhammad Jawad-Ul-Qamar, Mohammad Nawaz, Abdul Maher
Publikováno v:
Open Heart, Vol 7, Iss 1 (2020)
Objectives Prolonged ECG monitoring is clinically useful to detect unknown atrial fibrillation (AF) in stroke survivors. The diagnostic yield of prolonged ECG monitoring in other patient populations is less well characterised. We therefore studied th
Externí odkaz:
https://doaj.org/article/594332fb5a30444d8a818ccd28b5e01e
Autor:
Paulus Kirchhof, Michael D. Ezekowitz, Yanish Purmah, Sonja Schiffer, Isabelle L. Meng, A. John Camm, Stefan H. Hohnloser, Anke Schulz, Melanie Wosnitza, Riccardo Cappato
Publikováno v:
TH Open, Vol 04, Iss 01, Pp e20-e32 (2020)
Introduction This X-VeRT (eXplore the efficacy and safety of once-daily oral riVaroxaban for the prevention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion) substudy evaluated the effects of treat
Externí odkaz:
https://doaj.org/article/4684f89640f5438ab6e6f2148ca93bc5
Autor:
Renate B. Schnabel, Ladislav Pecen, Nargiz Rzayeva, Markus Lucerna, Yanish Purmah, Francisco M. Ojeda, Raffaele De Caterina, Paulus Kirchhof
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 11 (2018)
BackgroundLittle is known about the association of atrial fibrillation symptom burden with quality of life and outcomes. Methods and ResultsIn the Prevention of Thromboembolic Events–European Registry in Atrial Fibrillation (n=6196 patients with at
Externí odkaz:
https://doaj.org/article/5e21e95e5fe447dfa43292c00bdafa4e
Autor:
Winnie Chua, Frantisek Nehaj, Yanish Purmah, Peter Kastner, Paul Brady, André Ziegler, Larissa Fabritz, A Khashaba, Paulus Kirchhof
Publikováno v:
European Heart Journal. 42
Background/Introduction Cardiovascular (CV) diseases including atrial fibrillation and arteriosclerosis are associated with impaired cognitive function. Cognitive dysfunction can impact the process of shared clinical decision making, reduce adherence
Autor:
Nowell M. Fine, Rosa Sandonato, Steven Dykstra, Yoko Mikami, Lucy Y. Lei, Bobak Heydari, Carmen P Lydell, Michelle Seib, Aidan Cornhill, Jacqueline Flewitt, Alessandro Satriano, Juan Gaztanaga, Michael R. Bristow, Sandra Rivest, James A. White, Andrew G Howarth, Naeem Merchant, Yanish Purmah
Publikováno v:
Circulation. Cardiovascular imaging. 14(3)
Background: There is increasing evidence that right ventricular ejection fraction (RVEF) may provide incremental value to left ventricular (LV) ejection fraction for the prediction of major adverse cardiovascular events. To date, generalizable utilit
Autor:
Georgios V. Gkoutos, Winnie Chua, Kalisha Russell, Charles J. Ferro, Paul Brady, Frantisek Nehaj, Samantha Tull, Davor Pavlovic, Jonathan P Law, Paulus Kirchhof, Yanish Purmah, Victor Roth Cardoso, Muhammad Jawad-Ul-Qamar, Larissa Fabritz, André Ziegler, Ashley Turner, Peter Kastner, Georgiana Neculau
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 18, Iss 2, p e1003405 (2021)
PLoS Medicine, Vol 18, Iss 2, p e1003405 (2021)
Background Large-scale screening for atrial fibrillation (AF) requires reliable methods to identify at-risk populations. Using an experimental semi-quantitative biomarker assay, B-type natriuretic peptide (BNP) and fibroblast growth factor 23 (FGF23)
Autor:
Stefan Kääb, Paulus Kirchhof, Ulrich Schotten, Harry J.G.M. Crijns, Victor Roth Cardoso, Moritz F. Sinner, Peter Kastner, André Ziegler, Georgios V. Gkoutos, Stef Zeemering, Stéphane N. Hatem, Jasmeet S. Reyat, Elton A. M. P. Dudink, Eduard Guasch, Frantisek Nehaj, Larissa Fabritz, Winnie Chua, Barbara Casadei, Lluís Mont, Yanish Purmah, Paul Brady
Publikováno v:
SSRN Electronic Journal.
Background: Early detection of atrial fibrillation (AF) and subsequent initiation of anticoagulation and rhythm control therapy markedly reduce stroke, cardiovascular death, and heart failure, but unselected ECG screening for AF is time- and resource